Kanzaki Sho, Watanabe Kotaro, Fujioka Masato, Shibata Shinsuke, Nakamura Masaya, Okano Hirotaka James, Okano Hideyuki, Ogawa Kaoru
Department of Otolaryngology Head and Neck Surgery, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Department of Otolaryngology Head and Neck Surgery, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Hear Res. 2015 Dec;330(Pt A):142-6. doi: 10.1016/j.heares.2015.09.018. Epub 2015 Oct 3.
Systemic application of drugs is commonly used in clinical situations. Some of these drugs are ototoxic. Since there are few studies on in vivo monitoring of drug delivery dynamics, the time course or bioavailability of drugs in the inner ear of live animals following systemic drug application remains unknown. For instance, it is unknown whether the volume of a drug delivered systemically correlates with its inner ear pharmacokinetics. We previously established a new in vivo imaging system to monitor drug delivery in live mice. In the present study, we used this system to compare drug concentration in the inner ear over time after systemic drug injections. We used transgenic GFAP-Luc mice that harbor a firefly luciferase gene expression cassette regulated by 12 kb of murine GFAP promoter and human beta-globin intron 2. Luciferin delivered into the inner ear of these mice reacts with luciferase, and the resulting signals are detected in GFAP-expressing cells in the cochlear nerve. Thus, we assessed in the inner ear the intensity and duration of luciferin/luciferase signals after systemic injections of different volumes of luciferin. An IVIS(®) imaging system was used to observe signals, and these signals were compared to the drug dynamics of luciferin delivered through subcutaneous (sc) injections. The volume of sc-injected drug correlated significantly with photon counts measured in the inner ear. Photons were detected almost immediately after injection, peaking 20 min after injection. Drug concentration did not affect inner ear signals. Luciferin injected systemically appeared in the inner ear between highest and lowest concentration. Drug volume is an important parameter to know if the inner ear requires a higher level of the drug. We observed that it is the volume of a drug-not its concentration-that is the important factor. Indeed, the more volume of a drug injected systemically increased the concentration of that drug in the inner ear. This study provides a better understanding of in vivo drug delivery dynamics measured in the inner ear. Further studies will show whether a high dosage of drug is effective or not.
药物的全身应用在临床中很常用。其中一些药物具有耳毒性。由于关于体内药物递送动力学监测的研究较少,全身应用药物后活体内耳中药物的时间进程或生物利用度仍不清楚。例如,全身递送的药物体积与其内耳药代动力学是否相关尚不清楚。我们之前建立了一种新的体内成像系统来监测活小鼠体内的药物递送。在本研究中,我们使用该系统比较全身注射药物后内耳中药物浓度随时间的变化。我们使用了转基因GFAP-Luc小鼠,其携带由12 kb小鼠GFAP启动子和人β-珠蛋白内含子2调控的萤火虫荧光素酶基因表达盒。注入这些小鼠内耳的荧光素与荧光素酶反应,在耳蜗神经中表达GFAP的细胞中检测到产生的信号。因此,我们评估了全身注射不同体积荧光素后内耳中荧光素/荧光素酶信号的强度和持续时间。使用IVIS(®)成像系统观察信号,并将这些信号与通过皮下(sc)注射递送的荧光素的药物动力学进行比较。sc注射药物的体积与内耳中测量的光子计数显著相关。注射后几乎立即检测到光子,在注射后20分钟达到峰值。药物浓度不影响内耳信号。全身注射的荧光素在内耳中出现在最高和最低浓度之间。药物体积是了解内耳是否需要更高水平药物的一个重要参数。我们观察到,重要的因素是药物的体积而非其浓度。实际上,全身注射的药物体积越大,该药物在内耳中的浓度就越高。这项研究有助于更好地理解在内耳中测量的体内药物递送动力学。进一步的研究将表明高剂量药物是否有效。